Evidence map›Paper›PMID 38406276›Full record

ArticlePeerJ2024

MX1 and UBE2L6 are potential metaflammation gene targets in both diabetes and atherosclerosis.

Guisheng Wang, Rongrong Hua, Xiaoxia Chen, Xucheng He, Yao Dingming, Hua Chen, Buhuan Zhang, Yuru Dong, Muqing Liu, Jiaxiong Liu and 4 more

Open access · goldAbstract read
In one paragraph

Article in PeerJ, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
3.6field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Ubiquitin-conjugating Enzymes in Cancer.International journal of biological sciences · 2026
    Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 1 country.

Guisheng Wang *Department of Radiology, Third Medical Center of Chinese PLA General Hospital, Beijing, China.
Rongrong Hua *Department of Radiology, Third Medical Center of Chinese PLA General Hospital, Beijing, China.ORCID 0000-0001-5102-115X
Xiaoxia ChenDepartment of Radiology, Third Medical Center of Chinese PLA General Hospital, Beijing, China.
Xucheng HeDepartment of Radiology, Third Medical Center of Chinese PLA General Hospital, Beijing, China.
Yao DingmingDepartment of Radiology, Third Medical Center of Chinese PLA General Hospital, Beijing, China.
Hua ChenLaboratory Animal Center, Chinese People's Liberation Army General Hospital, Beijing, China.
Buhuan ZhangDepartment of Radiology, Third Medical Center of Chinese PLA General Hospital, Beijing, China.
Yuru DongDepartment of Radiology, Third Medical Center of Chinese PLA General Hospital, Beijing, China.
Muqing LiuDepartment of Radiology, Third Medical Center of Chinese PLA General Hospital, Beijing, China.
Jiaxiong LiuDepartment of Radiology, Third Medical Center of Chinese PLA General Hospital, Beijing, China.
Ting LiuDepartment of Radiology, Beijing YouAn Hospital, Capital Medical University, Beijing, China.
Jingwei ZhaoDepartment of Radiology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Yu Qiong ZhaoLaboratory Animal Center, Chinese People's Liberation Army General Hospital, Beijing, China.
Li QiaoDepartment of International Business, Business College of Beijing Union University, Beijing, China.
Chinese PLA General Hospital · CNChinese People's Liberation Army · CNBeijing Union University · CNCapital Medical University · CNChinese Academy of Medical Sciences & Peking Union Medical College · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The coexistence of diabetes mellitus (DM) and atherosclerosis (AS) is widespread, although the explicit metabolism and metabolism-associated molecular patterns (MAMPs) responsible for the correlation are still unclear. Methods: Twenty-four genetically wild-type male Ba-Ma mini pigs were randomly divided into five groups distinguished by different combinations of 90 mg/kg streptozotocin (STZ) intravenous injection and high-cholesterol/lipid (HC) or high-lipid (HL) diet feeding for 9 months in total. Pigs in the STZ+HC and STZ+HL groups were injected with STZ first and then fed the HC or HL diet for 9 months. In contrast, pigs in the HC+STZ and HL+STZ groups were fed the HC or HL diet for 9 months and injected with STZ at 3 months. The controls were only fed a regular diet for 9 months. The blood glucose and abdominal aortic plaque observed through oil red O staining were used as evaluation indicators for successful modelling of DM and AS. A microarray gene expression analysis of all subjects was performed. Results: Atherosclerotic lesions were observed only in the HC+STZ and STZ+HC groups. A total of 103 differentially expressed genes (DEGs) were identified as common between them. The most significantly enriched pathways of 103 common DEGs were influenza A, hepatitis C, and measles. The global and internal protein-protein interaction (PPI) networks of the 103 common DEGs consisted of 648 and 14 nodes, respectively. The top 10 hub proteins, namely, ISG15, IRG6, IRF7, IFIT3, MX1, UBE2L6, DDX58, IFIT2, USP18, and IFI44L, drive aspects of DM and AS. MX1 and UBE2L6 were the intersection of internal and global PPI networks. The expression of MX1 and UBE2L6 was 507.22 ± 342.56 and 96.99 ± 49.92 in the HC+STZ group, respectively, which was significantly higher than others and may be linked to the severity of hyperglycaemia-related atherosclerosis. Further PPI network analysis of calcium/micronutrients, including MX1 and UBE2L6, consisted of 58 and 18 nodes, respectively. The most significantly enriched KEGG pathways were glutathione metabolism, pyrimidine metabolism, purine metabolism, and metabolic pathways. Conclusions: The global and internal PPI network of the 103 common DEGs consisted of 648 and 14 nodes, respectively. The intersection of the nodes of internal and global PPI networks was MX1 and UBE2L6, suggesting their key role in the comorbidity mechanism of DM and AS. This inference was partly verified by the overexpression of MX1 and UBE2L6 in the HC+STZ group but not others. Further calcium- and micronutrient-related enriched KEGG pathway analysis supported that MX1 and UBE2L6 may affect the inflammatory response through micronutrient metabolic pathways, conceptually named metaflammation. Collectively, MX1 and UBE2L6 may be potential common biomarkers for DM and AS that may reveal metaflammatory aspects of the pathological process, although proper validation is still needed to determine their contribution to the detailed mechanism.

Indexed as

AtherosclerosisDiabetes MellitusAnimalsLipidsMaleMicronutrientsMyxovirus Resistance ProteinsStreptozocinSwineSwine, MiniatureUbiquitin-Conjugating EnzymesLipidsMicronutrientsMyxovirus Resistance ProteinsStreptozocinUbiquitin-Conjugating EnzymesAtherosclerosisBiomarker signaturesDiabetesDifferentially expressed genesProtein–protein interaction

Identifiers

PMID38406276
PMCPMC10893863
OpenAlexW4391999558

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.